[1]
“DEVELOPMENT OF ANTITUMOR DENDRITIC CELL VACCINES WITH ALDH1A2 INHIBITORS TO OVERCOME IMMUNE SUPPRESSION”, rjnmsr, vol. 4, no. 3, pp. 659–676, Jun. 2026, doi: 10.63075/1dpm7056.